Smith L F, Smith T T, Yeary E, McGee J M, Malnar K
Department of Surgery, University of Oklahoma Health Sciences Center, Tulsa 74129, USA.
J Okla State Med Assoc. 1999 Mar;92(3):126-30.
During the 1960s, injecting liquid silicone into the breasts for augmentation purposes was a common practice. Many women suffered complications, usually developing silicone mastopathy, but there have been reports of carcinoma as well. A case of squamous cell carcinoma of the breast is reported in a patient who had previously undergone injection of silicone into the breasts. Upon review of the literature, this is only the second reported case of squamous cell carcinoma of the breast following silicone injection. Squamous cell carcinoma of the breast is a very rare tumor comprising 0.04 to 0.075 percent of all breast malignancies. The tumor appears to develop from metaplasia of benign epithelial cells within the breast. Many theories are presented for the development of this metaplastic process. The clinical presentation, evaluation, and treatment of squamous cell carcinoma of the breast is quite similar to that of infiltrating ductal carcinoma of the breast of comparable stage and size.
在20世纪60年代,为了隆胸而向乳房注射液态硅胶是一种常见的做法。许多女性出现了并发症,通常发展为硅胶性乳腺病,但也有患癌的报告。本文报告了一例曾接受过乳房硅胶注射的患者发生乳腺鳞状细胞癌的病例。经查阅文献,这是第二例报道的注射硅胶后发生乳腺鳞状细胞癌的病例。乳腺鳞状细胞癌是一种非常罕见的肿瘤,占所有乳腺恶性肿瘤的0.04%至0.075%。该肿瘤似乎由乳腺内良性上皮细胞的化生发展而来。关于这种化生过程的发生提出了许多理论。乳腺鳞状细胞癌的临床表现、评估和治疗与相同分期和大小的乳腺浸润性导管癌非常相似。